January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...
Pharmaceutical companies just raised list prices for over 500 medicines, including Novo Nordisk’s Ozempic, Gilead’s HIV-1 ...
The residential real estate market is slowly shaking off the cobwebs of a sluggish year of buying and selling, and ...
The prices of the 25 most expensive brand-name drugs covered by Medicare Part D have nearly doubled, rising by an average of 98% since they entered the market, according to a new analysis by the AARP ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Bayer’s Nexavar and Boehringer Ingelheim's Spiriva are among a handful of drugs with reduced US list prices for the new year, ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...